MGI(688114) Zhi Tong Cai Jing·2025-06-03 00:45Group 1 - Shenzhen BGI Genomics Co., Ltd. won a bid for the Shanghai CDC biobank storage and management facility project with a bid amount of 50.5 million RMB [1] - The project aims to provide an advanced biobank storage and management system for the Shanghai CDC, highlighting the importance of biobanks in public health and medical research [1] - Biobanks are considered a strategic initiative for developing core competitiveness in the life sciences sector, supporting disease prevention, research, and precision medicine [1] Group 2 - BGI Genomics is a leading company in the domestic gene sequencing market, focusing on large-scale, high-throughput, and low-cost life digitalization products [2] - The company is prioritizing the development of ultra-low temperature automated biobank systems, customizing solutions for users to ensure stability, safety, and efficiency [2] - Recent upgrades to the existing ultra-low temperature automated storage system include the addition of AI visual calibration technology to enhance equipment precision and operational efficiency [2]